FDA-Approval for Bevacizumab-awwb for Treatment of Advanced Cancers

Bevacizumab-awwb has received US FDA approval for the treatment of several cancers. The introduction of a competitor to bevacizumab could possibly help to reduce cost of treatment and increase the availability of the medication, thus ensuring that more patients experience the benefits of the treatment.

Related Links